A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

NCT04650399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chikungunya

Interventions

BIOLOGICAL: Active
BIOLOGICAL: Placebo

Sponsor

Butantan Institute

Collaborators

[object Object]